These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 7567062)

  • 1. Characterization of immunoglobulin G-degrading proteases of Prevotella intermedia and Prevotella nigrescens.
    Jansen HJ; Grenier D; Van der Hoeven JS
    Oral Microbiol Immunol; 1995 Jun; 10(3):138-45. PubMed ID: 7567062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An investigation into the use of SDS-PAGE of cell surface extracts and proteolytic activity to differentiate Prevotella nigrescens and Prevotella intermedia.
    Cookson AL; Wray A; Handley PS; Jacob AE
    FEMS Microbiol Lett; 1996 Feb; 136(2):109-15. PubMed ID: 8869494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein degradation by Prevotella intermedia and Actinomyces meyeri supports the growth of non-protein-cleaving oral bacteria in serum.
    Jansen HJ; van der Hoeven JS
    J Clin Periodontol; 1997 May; 24(5):346-53. PubMed ID: 9178115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrolytic and depolymerising enzyme activity of Prevotella intermedia and Prevotella nigrescens.
    Stubbs S; Lewis MA; Waddington RJ; Embery G
    Oral Dis; 1996 Dec; 2(4):272-8. PubMed ID: 9171510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Prevotella and Capnocytophaga immunoglobulin A1 proteases by human serum.
    Frandsen EV; Kjeldsen M; Kilian M
    Clin Diagn Lab Immunol; 1997 Jul; 4(4):458-64. PubMed ID: 9220164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteinase activity of prevotella species associated with oral purulent infection.
    Yanagisawa M; Kuriyama T; Williams DW; Nakagawa K; Karasawa T
    Curr Microbiol; 2006 May; 52(5):375-8. PubMed ID: 16586023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of SpeB and EndoS from Streptococcus pyogenes on human immunoglobulins.
    Collin M; Olsén A
    Infect Immun; 2001 Nov; 69(11):7187-9. PubMed ID: 11598100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occurrence of Prevotella nigrescens and Prevotella intermedia in infections of endodontic origin.
    Bae KS; Baumgartner JC; Shearer TR; David LL
    J Endod; 1997 Oct; 23(10):620-3. PubMed ID: 9587274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Confirmation of the species Prevotella intermedia and Prevotella nigrescens.
    Frandsen EV; Poulsen K; Kilian M
    Int J Syst Bacteriol; 1995 Jul; 45(3):429-35. PubMed ID: 8590668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the human immunoglobulin G Fc-binding activity in Prevotella intermedia.
    Labbé S; Grenier D
    Infect Immun; 1995 Jul; 63(7):2785-9. PubMed ID: 7790101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of glucose on formation of cytotoxic end-products and proteolytic activity of Prevotella intermedia, Prevotella nigrescens and Porphyromonas gingivalis.
    Saito K; Takahashi N; Horiuchi H; Yamada T
    J Periodontal Res; 2001 Dec; 36(6):355-60. PubMed ID: 11762870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and polymerase chain reaction for differentiation of Prevotella intermedia and Prevotella nigrescens.
    Baumgartner JC; Bae KS; Xia T; Whitt J; David LL
    J Endod; 1999 May; 25(5):324-8. PubMed ID: 10530254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activation of the hemolysin in Prevotella nigrescens ATCC 33563 and Prevotella intermedia ATCC 25611.
    Silva TA; Noronha FS; de Macêdo Farias L; Carvalho MA
    Res Microbiol; 2004; 155(1):31-8. PubMed ID: 14759706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degradation of immunoglobulin G by periodontal bacteria.
    Jansen HJ; van der Hoeven JS; van den Kieboom CW; Göertz JH; Camp PJ; Bakkeren JA
    Oral Microbiol Immunol; 1994 Dec; 9(6):345-51. PubMed ID: 7870469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of human B-lymphocytes by Prevotella intermedia.
    Homayounfar A; Bergström J; Hammarström L
    Swed Dent J; 1999; 23(1):11-5. PubMed ID: 10371001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial degradation of immunoglobulin A1 in relation to periodontal diseases.
    Grønbaek Frandsen EV
    APMIS Suppl; 1999; 87():1-54. PubMed ID: 10189832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding and utilization of human transferrin by Prevotella nigrescens.
    Duchesne P; Grenier D; Mayrand D
    Infect Immun; 1999 Feb; 67(2):576-80. PubMed ID: 9916061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and genetic characterization of a Prevotella intermedia/nigrescens-like organism.
    Könönen E; Mättö J; Väisänen-Tunkelrott ML; Frandsen EV; Helander I; Asikainen S; Finegold SM; Jousimies-Somer H
    Int J Syst Bacteriol; 1998 Jan; 48 Pt 1():39-46. PubMed ID: 9542074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Prevotella intermedia and Prevotella nigrescens by enzyme production, restriction endonuclease and ribosomal RNA gene restriction analyses.
    Pearce MA; Dixon RA; Gharbia SE; Shah HN; Devine DA
    Oral Microbiol Immunol; 1996 Jun; 11(3):135-41. PubMed ID: 8941766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal periodontitis and prematurity. Part II: Maternal infection and fetal exposure.
    Madianos PN; Lieff S; Murtha AP; Boggess KA; Auten RL; Beck JD; Offenbacher S
    Ann Periodontol; 2001 Dec; 6(1):175-82. PubMed ID: 11887461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.